Final Thoughts Medicaid GLP-1 coverage in 2026 breaks down cleanly: diabetes is covered everywhere, cardiovascular disease and sleep apnea indications are covered most places, and obesity treatment remains a patchwork
Add leafy greens to the salad for an extra boost
58 GLP-2 The primary physiological effect of GLP-2 appears to be within the intestine, where GLP-2 promotes small and large intestinal growth through stimulating cell proliferation and inhibiting apoptosis in the crypt compartment
The relationship between GLP-1 and hair loss is complex and likely multifaceted, involving various factors that may contribute to hair shedding
However, people who have established strong exercise habits (particularly resistance training) and high-protein dietary patterns during treatment tend to regain less
It is continuing the development of an oral GIPR antagonist candidate (PF-07976016) in Phase 2, and maintains an earlier-stage obesity pipeline
